MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-20-0013994
Viplus Pharmaceuticals Private Limited
Viplus Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹109.48 Cr
▲ 83% YoY
Net profit · FY 2024
₹3.06 Cr
Net margin 2.8%
EBITDA · FY 2024
₹6.83 Cr
EBITDA margin 6.2%
Authorised capital
₹4.01 Cr
Registered with MCA
Paid-up capital
₹2.01 Cr
Issued & subscribed
Open charges
₹36.84 Cr
Satisfied ₹15 Cr
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
About Viplus Pharmaceuticals Private Limited
Data last updated:
Viplus Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2020PTC145526. Its GSTIN is 36AAHCV7144C1ZC (Telangana).
The company has an authorised share capital of ₹4.01 Cr and a paid-up capital of ₹2.01 Cr. It is led by directors including Prakash Reddy Vinta and Satwick Reddy Vinta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 104 Block No.2 Hydernagar Village, Hyderabad, Telangana, India – 500085.
As per the financials filed for FY 2024, the company reported a revenue of ₹109.48 Cr, a growth of 83% compared to the previous year. For the same year it recorded a net profit of ₹3.06 Cr (net margin 2.8%) and EBITDA of ₹6.83 Cr (EBITDA margin 6.2%).
As per MCA filings, the company has open charges of ₹36.84 Cr and satisfied charges of ₹15 Cr on record.
Viplus Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-20-0013994).
Company details
CIN U24299TG2020PTC145526
Registration Number 145526
Incorporation Date 03 November 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification MSME
Udyam Registration UDYAM-TS-20-0013994
Recognitions & Rankings of Viplus Pharmaceuticals
Contact details
Viplus Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 104 Block No.2 Hydernagar Village, Hyderabad, Telangana, India – 500085
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Viplus Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Viplus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Viplus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Viplus Pharmaceuticals Private Limited, buy the company report.
Financials of Viplus Pharmaceuticals Private Limited
FY 2025 filings availableViplus Pharmaceuticals Private Limited reported revenue of ₹109.48 Cr (up 83% YoY) for FY 2024.
Revenue · FY 2024
₹109.48 Cr ▲ 83%
Net profit · FY 2024
₹3.06 Cr margin 2.8%
EBITDA · FY 2024
₹6.83 Cr margin 6.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 83%
EBITDA CAGR growth
1 year
▲ 381%
Revenue rose 83% in the latest year. EBITDA rose 381% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹109.48 Cr | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹6.83 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹3.06 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6.2% | |||
| Net Profit Margin | 2.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Viplus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Viplus Pharmaceuticals Private Limited
Viplus Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prakash Reddy Vinta | Director | 03 Nov 2020 | 5 Years 11 Months | Current |
| Satwick Reddy Vinta Also directs: NK Chemicals Pvt Ltd, Aditri Pharma Sciences Private Limited | Director | 03 Nov 2022 | 3 Years 11 Months | Current |
| Sashank Reddy Vinta Also directs: Vinta Laboratories Private Limited, Vinta Labs Private Limited, Care-Ind Chem Private Limited and 2 more | Director | 03 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Viplus Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Recova Pharma Expo Private Limited | ₹110.65 Cr (FY 2025) | 85.0% | New Delhi, Delhi, India | |||
| Saisun Pharma Private Limited | ₹110.47 Cr (FY 2025) | 28.0% | Delhi, India | |||
| Shakun Sales Private Limited | ₹110.07 Cr (FY 2025) | 54.0% | Uttar Pradesh, India | |||
| Ar Kay Medicos Private Limited | ₹109.57 Cr (FY 2025) | -2.0% | New Delhi, Delhi, India | |||
| Viplus Pharmaceuticals Private Limitedthis company | ₹109.48 Cr (FY 2024) | ₹3.06 Cr | 2.8% | 83.0% | Hyderabad, Telangana, India | |
| Meyonex Pharmaceuticals Limited | ₹108.15 Cr (FY 2025) | -19.0% | Palghar, Maharashtra, India |
To see the full peer comparison of Viplus Pharmaceuticals Private Limited, buy the company report.
Auditor
Viplus Pharmaceuticals Private Limited is audited by Shah Baxi & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Shah Baxi & Associates | FY 2024 | 131879W |
Shareholding
The shareholding of Viplus Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Viplus Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹36.84 Cr
Satisfied charges
₹15 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Aug 2026 | 101378555 | Axis Bank Limited | ₹5.98 Cr | Open | |
| 31 Jan 2026 | 101226632 | Others | ₹25.5 Lakh | Open | |
| 04 Aug 2023 | 100769128 | Axis Bank Limited | ₹29.95 Cr | Open | |
| 29 Jun 2023 | 100748006 | Others | ₹65 Lakh | Open | |
| 31 Jan 2022 | 100537810 | Others | ₹15 Cr | Satisfied |
To see the full charge records of Viplus Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Viplus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Viplus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Viplus Pharmaceuticals Private Limited has 1 active EPFO establishment as of Sep 25, 2025.
Active EPFO establishments
1
GST
Viplus Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHCV7144C1ZC | Telangana | Active | 13 Mar 2021 |
To see the full GST registrations and return filing status of Viplus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Viplus Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Satwick Reddy Vinta was appointed as Director on 03 Nov 2022.
Charges
A charge with Axis Bank Limited amounted to Rs. 5.98 Cr with Charge ID 101378555 was registered on 18 Aug 2026.
Charges
A charge with Others amounted to Rs. 0.26 Cr with Charge ID 101226632 was registered on 31 Jan 2026.
AGM
Viplus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Viplus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited of Rs. 29.95 Cr registered on 04 Aug 2023 with Charge ID 100769128 was modified on 20 Feb 2025.
Charges
A charge registered on 31 Jan 2022 via Charge ID 100537810 with Others was fully satisfied on 16 Oct 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 29.95 Cr with Charge ID 100769128 was registered on 04 Aug 2023.
Charges
A charge with Others amounted to Rs. 0.65 Cr with Charge ID 100748006 was registered on 29 Jun 2023.
Appointed
Satwick Reddy Vinta was appointed as Director.
Charges
A charge with Others of Rs. 15.00 Cr registered on 31 Jan 2022 with Charge ID 100537810 was modified on 23 Sep 2022.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100537810 was registered on 31 Jan 2022.
Appointed
Prakash Reddy Vinta was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Viplus Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 November 2020 (6+ years old) and is registered under CIN U24299TG2020PTC145526.
Viplus Pharmaceuticals has 3 current directors:
- Prakash Reddy Vinta - Director
- Satwick Reddy Vinta - Director
- Sashank Reddy Vinta - Director
The latest financial statements of Viplus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Viplus Pharmaceuticals is 36AAHCV7144C1ZC, registered in Telangana.
The CIN (Corporate Identification Number) of Viplus Pharmaceuticals is U24299TG2020PTC145526. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Viplus Pharmaceuticals was incorporated on 03 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Viplus Pharmaceuticals by revenue are Recova Pharma Expo Private Limited, Saisun Pharma Private Limited, Shakun Sales Private Limited, Ar Kay Medicos Private Limited, Meyonex Pharmaceuticals Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Satwick Reddy Vinta was appointed as Director on 03 Nov 2022. Prakash Reddy Vinta was appointed as Director on 03 Nov 2020. Sashank Reddy Vinta was appointed as Director on 03 Nov 2020.
Yes, Viplus Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-TS-20-0013994).
The registered office of Viplus Pharmaceuticals is at Flat No. 104 Block No.2 Hydernagar Village, Hyderabad, Telangana, India – 500085.
Viplus Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.